0001365916-22-000107.txt : 20220829 0001365916-22-000107.hdr.sgml : 20220829 20220829191033 ACCESSION NUMBER: 0001365916-22-000107 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220822 FILED AS OF DATE: 20220829 DATE AS OF CHANGE: 20220829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kung Frank CENTRAL INDEX KEY: 0001227255 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 221212498 MAIL ADDRESS: STREET 1: C/O VIVO CAPITAL STREET 2: 505 CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER NAME: FORMER CONFORMED NAME: KUNG FRANK DATE OF NAME CHANGE: 20030414 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 550856151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4/A 1 wf-form4a_166181461369437.xml FORM 4/A X0306 4/A 2022-08-22 2022-08-24 0 0001365916 AMYRIS, INC. AMRS 0001227255 Kung Frank C/O AMYRIS, INC. 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2022-08-22 4 A 0 80000 0 A 87409 D Common Stock 2022-08-23 4 J 0 7409 0 D 80000 D Common Stock 2022-08-23 4 J 0 7409 0 A 16207 I by Vivo Capital LLC Common Stock 6796205 I by Vivo Capital Fund VIII, L.P. Common Stock 3187518 I by Vivo Opportunity Fund, LP Common Stock 938416 I by Vivo Capital Surplus Fund VIII, L.P. Common Stock 711258 I by Vivo Capital Fund IX, LP Pursuant to an agreement dated November 2, 2017 between the Reporting Person and Vivo Capital LLC, the Reporting Person agreed to remit the equity compensation received under Issuer's non-employee director compensation program to Vivo Capital if and when such equity compensation becomes vested and/or exercised. The Reporting Person is a voting member of Vivo Capital LLC and may be deemed to share voting and dispositive power over these shares with five (5) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes. The General Partner of the holder is Vivo Capital VIII, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes. The General Partner of the holder is Vivo Opportunity, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes. The General Partner of the holder is Vivo Capital IX LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with six (6) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes. The Form 4 filed by the Reporting Person on August 24, 2022 inadvertently excluded the Reporting Person's transfer to indirect holdings as detailed in footnote 1 above. /s/ Frank Kung by Bruna Lawant Attorney-in-Fact 2022-08-29